Bausch + Lomb Corporation (NYSE:BLCO) Receives $15.54 Consensus PT from Brokerages

Shares of Bausch + Lomb Corporation (NYSE:BLCO - Get Free Report) have received a consensus rating of "Hold" from the thirteen research firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have given a buy rating to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $15.54.

Several brokerages have issued reports on BLCO. Citigroup lowered their target price on shares of Bausch + Lomb from $14.00 to $13.00 and set a "neutral" rating on the stock in a research note on Thursday, May 1st. Needham & Company LLC reissued a "hold" rating on shares of Bausch + Lomb in a research note on Thursday, April 24th. Royal Bank Of Canada dropped their target price on Bausch + Lomb from $18.00 to $17.00 and set an "outperform" rating for the company in a research report on Friday, April 4th. HC Wainwright decreased their target price on Bausch + Lomb from $20.00 to $15.00 and set a "buy" rating for the company in a report on Friday, May 2nd. Finally, Barclays reduced their price objective on shares of Bausch + Lomb from $19.00 to $16.00 and set an "equal weight" rating on the stock in a report on Monday, June 9th.

Insider Transactions at Bausch + Lomb

In other news, CEO Brent L. Saunders purchased 22,000 shares of the stock in a transaction dated Thursday, May 22nd. The stock was acquired at an average cost of $11.28 per share, for a total transaction of $248,160.00. Following the completion of the acquisition, the chief executive officer directly owned 719,156 shares in the company, valued at $8,112,079.68. This represents a 3.16% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 0.15% of the company's stock.

Institutional Investors Weigh In On Bausch + Lomb

A number of institutional investors have recently bought and sold shares of the stock. National Bank of Canada FI grew its holdings in shares of Bausch + Lomb by 101.7% during the 1st quarter. National Bank of Canada FI now owns 6,719 shares of the company's stock worth $97,000 after purchasing an additional 3,387 shares during the period. Commonwealth Equity Services LLC acquired a new stake in shares of Bausch + Lomb in the fourth quarter valued at about $181,000. Alpine Global Management LLC purchased a new stake in shares of Bausch + Lomb during the fourth quarter valued at approximately $181,000. Covestor Ltd purchased a new stake in Bausch + Lomb during the 4th quarter worth $188,000. Finally, Orion Portfolio Solutions LLC purchased a new position in Bausch + Lomb in the fourth quarter valued at about $225,000. 11.07% of the stock is currently owned by hedge funds and other institutional investors.

Bausch + Lomb Stock Performance

Shares of BLCO stock traded up $0.18 on Friday, hitting $13.63. The company had a trading volume of 776,799 shares, compared to its average volume of 708,489. The firm has a market cap of $4.82 billion, a P/E ratio of -13.23, a price-to-earnings-growth ratio of 1.47 and a beta of 0.62. Bausch + Lomb has a twelve month low of $10.45 and a twelve month high of $21.69. The company has a 50-day moving average price of $11.96 and a 200-day moving average price of $14.52. The company has a quick ratio of 0.96, a current ratio of 1.56 and a debt-to-equity ratio of 0.74.

Bausch + Lomb (NYSE:BLCO - Get Free Report) last announced its earnings results on Wednesday, April 30th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.10). Bausch + Lomb had a positive return on equity of 2.62% and a negative net margin of 7.50%. The business had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same period in the previous year, the company earned $0.07 earnings per share. The company's quarterly revenue was up 3.5% compared to the same quarter last year. As a group, equities research analysts predict that Bausch + Lomb will post 0.74 earnings per share for the current fiscal year.

Bausch + Lomb Company Profile

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief.